N(G)-nitro-L-arginine methyl ester inhibits bone metastasis after modified intracardiac injection of human breast cancer cells in a nude mouse model

Japanese Journal of Cancer Research

Volumn 88, Issue 9, 1997, Pages 861-866

  Iwasaki, Teruo ^a,b   Higashiyama, Masahiko ^a   Kuriyama, Keiko ^a   Sasaki, Akira ^c   Mukai, Mutsuko ^a   Shinkai, Kiyoko ^a   Horai, Takeshi ^a   Matsuda, Hikaru ^b   Akedo, Hitoshi ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

Author keywords

Bone metastasis; Human breast cancer; N(G) nitro L arginine methyl ester (L NAME); Nitric oxide (NO); Nude mouse model

Indexed keywords

N(G) NITRO DEXTRO ARGININE METHYL ESTER; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE METASTASIS; BONE RADIOGRAPHY; BREAST CANCER; CONTROLLED STUDY; HEART LEFT VENTRICLE; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; LAPAROTOMY; MALE; MOUSE; NONHUMAN; NUDE MOUSE; OSTEOLYSIS; PRIORITY JOURNAL; TUMOR CELL; TUMOR XENOGRAFT; ANIMAL; BONE TUMOR; BREAST TUMOR; FEMALE; HEART; HETEROTOPIC TRANSPLANTATION; INSTITUTE FOR CANCER RESEARCH MOUSE; METASTASIS; PATHOLOGY; RADIOGRAPHY; STEREOISOMERISM; XENOGRAFT;

ANIMALS; BONE NEOPLASMS; BREAST NEOPLASMS; FEMALE; HEART; HUMANS; MALE; MICE; MICE, INBRED ICR; MICE, NUDE; NG-NITROARGININE METHYL ESTER; STEREOISOMERISM; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTATION, HETEROTOPIC;

EID: 0030613746     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1997.tb00462.x     Document Type: Article

References (25)

1. Orr, F. W., Sanchez-Sweatman, O. H., Kostenuik, P. and Singh, G. Tumor-bone interactions in skeletal metastasis. Clin. Orthop., 312, 19-23 (1995).
2. Yoneda, T., Sasaki, A. and Mundy, G. R. Osteolytic bone metastasis in breast cancer. Breast Cancer Res. Treat., 32, 73-84 (1994).
3. Moncada, S., Palmer, R. M. J. and Higgs, E. A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev., 43, 109-142 (1991).
4. Andrade, S. P., Hart, I. R. and Piper, P. J. Inhibitors of nitric oxide synthase selectively reduce flow in tumour-associated neovasculature. Br. J. Pharmacol., 107, 1092-1095 (1992).
5. Jenkins, D. C., Charles, I. G., Thomsen, L. L., Moss, D. W., Holmes, L. S., Baylis, S. A., Rhodes, P., Westmore, K., Emson, P. C. and Moncada, S. Roles of nitric oxide in tumor growth. Proc. Natl. Acad. Sci. USA, 92, 4392-4396 (1995).
6. Doi, K., Akaike, T., Horie, H., Noguchi, Y., Fujii, S., Beppu, T., Ogawa, M. and Maeda, H. Excessive production of nitric oxide in rat solid tumor and its implication in rapid tumor growth. Cancer, 77, 1598-1604 (1996).
7. Fukumura, D., Yuan, F., Endo, M. and Jain, R. K. Role of nitric oxide in tumor microcirculation. Am. J. Pathol., 150, 713-725 (1997).
8. Radomski, M. W., Jenkins, D. C., Holmes, L. and Moncada, S. Human colorectal adenocarcinoma cells: differential nitric oxide synthesis determines their ability to aggregate platelets. Cancer Res., 51, 6073-6078 (1991).
9. Dong, Z., Staroselsky, A. H., Qi, X., Xie, K. and Fidler, I. J. Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells. Cancer Res., 54, 789-793 (1994).
10. Vidal, M. J., Zocchi, M. R., Poggi, A., Pellegatta, F. and Chierchia, S. L. Involvement of nitric oxide in tumor cell adhesion to cytokine-activated endothelial cells. J. Cardiovasc. Pharmacol., 20 (Suppl. 12), S155-S159 (1992).
11. Arguello, F., Baggs, R. B. and Frantz, C. N. A murine model of experimental metastasis to bone and bone marrow. Cancer Res., 48, 6876-6881 (1988).
12. Nakai, M., Mundy, G. R., Williams, P. J., Boyce, B. and Yoneda, T. A synthetic antagonist to laminin inhibits the formation of osteolytic metastases by human melanoma cells in nude mice. Cancer Res., 52, 5395-5399 (1992).
13. Sasaki, A., Boyce, B. F., Story, B., Wright, K. R., Chapman, M., Boyce, R., Mundy, G. R. and Yoneda, T. Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice. Cancer Res., 55, 3551-3557 (1995).
14. Iguchi, H., Tanaka, S., Ozawa, Y., Kashiwakuma, T., Kimura, T., Hiraga, T., Ozawa, H. and Kono, A. An experimental model of bone metastasis by human lung cancer cells: the role of parathyroid hormone-related protein in bone metastasis. Cancer Res., 56, 4040-4043 (1996).
15. G-Nitroarginine methyl ester exhibits antinociceptive activity in the mouse. Br. J. Pharmacol., 102, 198-202 (1991).
16. Shim, S. S. Physiology of blood circulation of bone. J. Bone Jt. Surg., 50-A, 812-824 (1968).
17. Kjønniksen, I., Nesland, J. M., Pihl, A. and Fodstad, Ø. Nude rat model for studying metastasis of human tumor cells to bone and bone marrow. J. Natl. Cancer Inst., 82, 408-412 (1990).
18. de Bruyn, P. P. H. and Michelson, S. An anionic material at the advancing front of blood cells entering the bone marrow circulation. Blood, 51, 152-156 (1981).
19. Maclntyre, I., Zaidi, M., Alam, A. S. M. T., Datta, H. K., Moonga, B. S., Lidbury, P. S., Hecker, M. and Vane, J. R. Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP. Proc. Natl. Acad. Sci. USA, 88, 2936-2940 (1991).
20. Nicolson, G. L. Cancer metastasis: tumor cell and host organ properties important in metastasis to specific secondary sites. Biochim. Biophys. Acta, 948, 175-224 (1988).
21. Greenblatt, E. P., Loeb, A. L. and Longnecker, D. E. Marked regional heterogeneity in the magnitude of EDRF/NO-mediated vascular tone in awake rats. J. Cardiovasc. Pharmacol., 21, 235-240 (1993).
22. G-nitro-L-arginine, an inhibitor of brain nitric oxide synthase, in obese Zucker rats. Eur. J. Pharmacol., 230, 125-128 (1993).
23. Gardiner, S. M., Compton, A. M., Bennett, T., Palmer, R. M. J. and Moncada, S. Control of regional blood flow by endothelium-derived nitric oxide. Hypertension, 15, 486-492 (1990).
24. G-nitro-L-arginine and/or L-arginine on experimental pulmonary metastasis in mice. Cancer Lett., 87, 115-120 (1994).
25. Hortobagyi, G. N., Theriault, R. L., Porter, L., Blayney, D., Lipton, A., Sinoff, C., Wheeler, H., Simeone, J. F., Seaman, J., Knight, R. D., Heffernan, M. and Reitsma, D. J. Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. N. Engl. J. Med., 335, 1785-1791 (1996).